A first-generation packaging cell line for Epstein-Barr virus-derived vectors
about
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfoldEpstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73αEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.Molecular virology of Epstein-Barr virus.Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.RNAs in Epstein-Barr virions control early steps of infection.The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression.The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAsDifferential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.Epstein-Barr virus genetics: talking about the BAC generation.An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.A virus-like particle-based Epstein-Barr virus vaccine.Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.Conditional gene vectors regulated in cis.Mutagenesis of the herpesvirus saimiri terminal repeat region reveals important elements for virus production.Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus.The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleusStandardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.A region of the Epstein-Barr virus (EBV) mRNA export factor EB2 containing an arginine-rich motif mediates direct binding to RNA.
P2860
Q24685733-83ACC45E-03E3-4414-A402-8F30B877A5BFQ28487983-16E3DB00-F7A5-4133-A7B8-39EA83BF84CBQ33860748-270ADC73-7982-40F2-A0E8-EC0B66A4A5EBQ33866016-567AC73F-98A2-4919-B576-ABBDDFBE0537Q33918592-DBBA6213-5A8B-4CEA-8129-3C98AAD5DE5CQ34081126-AF6AE27E-A9C7-46EC-8EE6-EC25ED4504ADQ34225554-B4DC196D-0401-4233-AE1A-E4C8BBD8F003Q34347652-ED5D5726-3A74-4AE5-8828-6CEAA059A0F1Q35165290-97CDD679-0794-40F1-A3CF-1720EF08AE1AQ35991530-BB1263E6-FF23-45EF-BF85-202F4F55962DQ36023187-62A69F19-C476-4EE8-87FE-633DE6F95EEFQ36079854-357B2C15-732D-474A-8A86-94F990FE5A36Q36144801-2D2D280F-BD81-4A7F-B015-9917A814F02CQ37237334-7CF1D75F-729C-4F23-A9D1-48BDAE467A2CQ37856451-400BF1C3-8E19-4AF0-B3A6-08B948DCA375Q39227077-2D2026B5-7170-43B1-BB2C-B875C43F97EAQ39458965-A4F4EDD4-98BB-47F8-84D0-EA699B10B698Q39609877-E81CE4B6-4C2D-446C-9421-5EB539A2F364Q39970553-0E3AF585-3F7F-48A8-A424-809F14F74246Q40146691-AFFB91B5-09C9-4D55-8033-47AC2EF20433Q40327889-788E66B5-E428-4E07-9965-788513A1F5E1Q40379092-1265AAF2-9D33-437E-B0EB-5823C5F97993Q40416450-27DD3439-CF6E-48C2-BAAB-F482B536E6D1Q42118228-CA855B2A-3B85-4F65-9F62-C62F9991E587Q42221268-68524851-6821-47BC-AF69-D1F3E476B671Q44511086-0BA4EADC-74F4-4281-927D-EAF338D2A975
P2860
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@ast
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@en
type
label
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@ast
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@en
prefLabel
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@ast
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@en
P2093
P2860
P356
P1476
A first-generation packaging cell line for Epstein-Barr virus-derived vectors
@en
P2093
T Hilsendegen
W Hammerschmidt
P2860
P304
P356
10.1073/PNAS.96.9.5188
P407
P577
1999-04-01T00:00:00Z